Anti-dopamine D2 receptor antibodies in chronic tic disorders
- PMID: 32644201
- DOI: 10.1111/dmcn.14613
Anti-dopamine D2 receptor antibodies in chronic tic disorders
Abstract
Aim: To investigate the association between circulating anti-dopamine D2 receptor (D2R) autoantibodies and the exacerbation of tics in children with chronic tic disorders (CTDs).
Method: One hundred and thirty-seven children with CTDs (108 males, 29 females; mean age [SD] 10y 0mo [2y 7mo], range 4-16y) were recruited over 18 months. Patients were assessed at baseline, at tic exacerbation, and at 2 months after exacerbation. Serum anti-D2R antibodies were evaluated using a cell-based assay and blinded immunofluorescence microscopy scoring was performed by two raters. The association between visit type and presence of anti-D2R antibodies was measured with McNemar's test and repeated-measure logistic regression models, adjusting for potential demographic and clinical confounders.
Results: At exacerbation, 11 (8%) participants became anti-D2R-positive ('early peri-exacerbation seroconverters'), and nine (6.6%) became anti-D2R-positive at post-exacerbation ('late peri-exacerbation seroconverters'). The anti-D2R antibodies were significantly associated with exacerbations when compared to baseline (McNemar's odds ratio=11, p=0.003) and conditional logistic regression confirmed this association (Z=3.49, p<0.001) after adjustment for demographic and clinical data and use of psychotropic drugs.
Interpretation: There is a potential association between immune mechanisms and the severity course of tics in adolescents with CTDs.
© 2020 Mac Keith Press.
Comment in
-
Can anti-dopamine D2 receptor autoantibodies explain fluctuations of tic severity?Dev Med Child Neurol. 2020 Oct;62(10):1118-1119. doi: 10.1111/dmcn.14626. Epub 2020 Jul 13. Dev Med Child Neurol. 2020. PMID: 32662071 No abstract available.
References
-
- Ganos C, Martino D. Tics and Tourette syndrome. Neurol Clin 2015; 33: 115-36.
-
- Martino D, Ganos C, Pringsheim TM. Tourette syndrome and chronic tic disorders: the clinical spectrum beyond tics. Int Rev Neurobiol 2017; 134: 1461-90.
-
- Godar SC, Bortolato M. What makes you tic? Translational approaches to study the role of stress and contextual triggers in Tourette syndrome. Neurosci Biobehav Rev 2017; 76: 123-33.
-
- Martino D, Zis P, Buttiglione M. The role of immune mechanisms in Tourette syndrome. Brain Res 2015; 18: 126-43.
-
- Robertson MM, Eapen V, Singer HS, et al. Gilles de la Tourette syndrome. Nat Rev Dis Primers 2017; 2: 16097.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources